Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age | NEJM - nejm.org

Original Article from The New England Journal of Medicine — Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

Trial Population Between March and August 2021, a total of 751 participants who were 6 to 11 years of age were enrolled in part 1 of the trial and 4016 participants were enrolled in part 2. In part … [+12851 chars]

full article...